Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04575727 · ClinicalTrials.gov registry record · Early Phase 1
Exploratory Evaluation of [11C]MPC6827
A Early Phase 1 study, sponsored by Columbia University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 17
- Enrollment target
NCT04575727 is a Early Phase 1 study that has completed, run by Columbia University. The registered enrollment target is 17 participants.
The verdict
NCT04575727, a Early Phase 1 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a phase 0 study that will enable an assessment of biodistribution and estimation of absorbed dose in humans based on data collected from five healthy volunteers, which is typically the minimum number required by the FDA for first-in-human studies to assess dosimetry of a new tracer. The evaluation of the brain imaging of thirty additional subjects in the 2nd part of the study will lead to a descriptive assessment of the targeting and pharmacokinetics of MPC6827 in the brain and between normal and diseased brain.
Interventions
- DRUG [11C]MPC6827
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-01-08 |
| Est. Completion | 2024-06-21 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04575727
The ClinicalTrials.gov registry entry for NCT04575727 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [11C]MPC6827 is the first listed.
NCT04575727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04575727 about?
NCT04575727 is a clinical study titled "Exploratory Evaluation of [11C]MPC6827". This is a phase 0 study that will enable an assessment of biodistribution and estimation of absorbed dose in humans based on data collected from five healthy volunteers, which is typically the minimum number required by the FDA for first-in-human studies to assess dosimetry of a new tracer. The eval...
What is the current status of trial NCT04575727?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 17 participants. The study started on 2021-01-08. Estimated completion is 2024-06-21.
What interventions are being tested in trial NCT04575727?
The interventions under investigation include: [11C]MPC6827 (DRUG).
Who is sponsoring clinical trial NCT04575727?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.